Zymeworks Inc. logo

Zymeworks Inc.

1937653

Zymeworks is a biotechnology company managing a portfolio of healthcare assets and developing novel, multifunctional biotherapeutics. They focus on optimizing cash flows from licensed products like Ziihera® (zanidatamab-hrii) and supporting early-stage development of innovative medicines. Their therapeutic platforms and integrated drug development engine engineer differentiated antibody-based therapeutics for themselves and partners. They aim to transform areas of high unmet medical need.

86
Meget Pålidelig
Tillidsscore

Officielt Register

Business.legalName
Zymeworks Inc.
CVR-nummer
1937653
Momsnummer
883099146
Virksomhedsstatus
Active
Adresse
108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE 19709
Branchekoder
Pharmaceutical Preparations, 2834

AI Kvalitetsanalyse

Branche
Biotechnology
SSL/HTTPS
Sikker
Professionel E-mail
Ja
Kontakt E-mail
bd@zymeworks.com

🌟 Lignende Troværdige Virksomheder

Metagenomi, Inc.

Metagenomi, Inc. logo
74/100 · Pålidelig

Metagenomi is an in vivo genome editing company creating curative genetic medicines using proprietary technologies. They leverage metagenomics to discover editing tools potentially capable of correcting any type of genetic mutation. The company focuses on diseases with well-understood biology and clear regulatory pathways, and intends to expand their pipeline through genetic editing capabilities.

5959 HORTON STREET, USA
Se profil

ARCTICZYMES TECHNOLOGIES ASA

ARCTICZYMES TECHNOLOGIES ASA logo
80/100 · Meget Pålidelig

ArcticZymes Technologies er en bioteknologivirksomhed, der specialiserer sig i udvikling og produktion af enzymer. De tilbyder nukleaser til biofremstilling og molekylær diagnostik, herunder Salt Active Nucleaser (SAN). Virksomheden er kendt for sine polymeraser og enzymer, der anvendes i forsknings- og industrielle applikationer.

Sykehusvegen 23, Norway
Se profil

ACD PHARMACEUTICALS AS

ACD PHARMACEUTICALS AS logo
80/100 · Meget Pålidelig

ACD Pharma is a Norwegian R&D company developing biocontrol products based on bacteriophages, focusing on combating harmful bacteria in animals and humans. They launched Custus®YRS, the world's first bacteriophage product for aquaculture. They collaborate with pharmaceutical and scientific teams to fight antibiotic resistance, extending their advancements across sectors.

Lofoten Bio Centre, Norway10 ansatte
Se profil